As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181

DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.

Read more »

Companies Rush to Create Swine Flu Vaccines

With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.

Read more »